We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTXR icon
2376
Citius Pharmaceuticals
CTXR
$19.9M
$8.67K ﹤0.01%
+289
New +$9.51K
EGAN icon
2377
eGain
EGAN
$199M
$8.67K ﹤0.01%
1,157
SWIM icon
2378
Latham Group
SWIM
$905M
$8.66K ﹤0.01%
2,334
+1,599
+218% +$4.88K
BWFG icon
2379
Bankwell Financial Group
BWFG
$547M
$8.63K ﹤0.01%
354
CBAN icon
2380
Colony Bankcorp
CBAN
$471M
$8.63K ﹤0.01%
916
+574
+168% +$5.45K
STRS
2381
DELISTED
STRATUS PPTYS INC
STRS
$8.61K ﹤0.01%
+328
New +$7.43K
AKYA
2382
DELISTED
Akoya BioSciences
AKYA
$8.61K ﹤0.01%
1,165
EVER icon
2383
EverQuote
EVER
$870M
$8.4K ﹤0.01%
1,292
LNZA icon
2384
LanzaTech
LNZA
$67.5M
$8.37K ﹤0.01%
+12
New +$4.74K
ATRA icon
2385
Atara Biotherapeutics
ATRA
$82.2M
$8.31K ﹤0.01%
206
FEAM icon
2386
5E Advanced Materials
FEAM
$68.9M
$8.27K ﹤0.01%
110
TNGX icon
2387
Tango Therapeutics
TNGX
$4.32B
$8.25K ﹤0.01%
2,484
IMA
2388
ImageneBio Inc
IMA
$67M
$8.24K ﹤0.01%
+105
New +$7.53K
SCWO icon
2389
374Water
SCWO
$46.6M
$8.23K ﹤0.01%
+344
New +$11K
PPTA
2390
Perpetua Resources
PPTA
$3.09B
$8.19K ﹤0.01%
+2,232
New +$10.3K
CATO icon
2391
Cato Corp
CATO
$66.5M
$8.16K ﹤0.01%
1,016
+691
+213% +$5.73K
GORV
2392
DELISTED
Lazydays
GORV
$8.14K ﹤0.01%
+23
New +$7.89K
BH icon
2393
Biglari Holdings Class B
BH
$1.24B
$8.08K ﹤0.01%
41
JAKK icon
2394
Jakks Pacific
JAKK
$292M
$8.01K ﹤0.01%
+401
New +$8.69K
VLD
2395
DELISTED
Velo3D, Inc.
VLD
$8K ﹤0.01%
106
+73
+221% +$5.09K
CRGE
2396
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$7.97K ﹤0.01%
8,134
OMGA
2397
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$7.97K ﹤0.01%
+1,423
New +$11.1K
MPX
2398
DELISTED
Marine Products Corp
MPX
$7.89K ﹤0.01%
+468
New +$6.91K
SMLR
2399
DELISTED
Semler Scientific
SMLR
$7.85K ﹤0.01%
+299
New +$7.88K
RSVR
2400
Reservoir Media
RSVR
$649M
$7.83K ﹤0.01%
1,301

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.